(-0.13%) 5 462.39 points
(-0.08%) 39 081 points
(0.12%) 17 739 points
(-0.04%) $80.80
(-3.74%) $2.65
(-0.74%) $2 313.50
(0.20%) $28.93
(1.86%) $1 004.70
(0.32%) $0.936
(0.71%) $10.68
(0.48%) $0.792
(0.29%) $87.75
Live Chart Being Loaded With Signals
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients...
Stats | |
---|---|
आज की मात्रा | 213 523 |
औसत मात्रा | 1.05M |
बाजार मूल्य | 115.04M |
EPS | $-0.350 ( Q1 | 2024-05-14 ) |
अगली कमाई की तारीख | ( $-0.350 ) 2024-08-14 |
Last Dividend | $0.0100 ( 2018-09-21 ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.480 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00600 (0.43%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-05 | Aftab Blake | Buy | 336 911 | Stock Option (Right to Buy) |
2024-06-05 | Galimi Francesco | Buy | 375 077 | Stock Option (Right to Buy) |
2024-06-05 | Harvey Brian Nicholas | Buy | 374 829 | Stock Option (Right to Buy) |
2024-06-05 | Healey Don | Buy | 271 595 | Stock Option (Right to Buy) |
2024-06-05 | Schor Chen | Buy | 1 770 427 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
69.91 |
Last 100 transactions |
Buy: 16 146 346 | Sell: 3 814 091 |
मात्रा सहसंबंध
Aceto Corporation सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध | |
---|---|
OZEM | 1 |
ENSC | 0.864 |
BBGI | 0.864 |
PEV | 0.863 |
TOI | 0.857 |
SYPR | 0.856 |
OPOF | 0.855 |
CNTG | 0.85 |
DRTS | 0.849 |
FXNC | 0.847 |
10 सबसे अधिक नकारात्मक सहसंबंध | |
---|---|
SSIC | -0.878 |
VCTR | -0.874 |
JAN | -0.863 |
FRLA | -0.856 |
MWFLX | -0.847 |
BNTC | -0.846 |
BNIX | -0.846 |
PRIM | -0.841 |
SLAM | -0.841 |
CTRE | -0.838 |
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Aceto Corporation सहसंबंध - मुद्रा/वस्त्र
Aceto Corporation वित्तीय
Annual | 2023 |
राजस्व: | $0 |
सकल लाभ: | $-6.10M (0.00 %) |
EPS: | $-3.31 |
FY | 2023 |
राजस्व: | $0 |
सकल लाभ: | $-6.10M (0.00 %) |
EPS: | $-3.31 |
FY | 2022 |
राजस्व: | $24.99M |
सकल लाभ: | $19.98M (79.96 %) |
EPS: | $-1.630 |
FY | 2021 |
राजस्व: | $9.73M |
सकल लाभ: | $9.73M (100.00 %) |
EPS: | $-2.00 |
Financial Reports:
No articles found.
Aceto Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.100 | 2009-06-11 |
Last Dividend | $0.0100 | 2018-09-21 |
Next Dividend | $0 | N/A |
Payout Date | 2018-10-09 | |
Next Payout Date | N/A | |
# dividends | 32 | -- |
Total Paid Out | $2.12 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.82 | -- |
Div. Sustainability Score | 0.755 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0.0850 | 0.75% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
21 Sep 2018 | $0.0100 | 06 Sep 2018 | 24 Sep 2018 | 09 Oct 2018 |
07 Jun 2018 | $0.0100 | 03 May 2018 | 08 Jun 2018 | 22 Jun 2018 |
08 Mar 2018 | $0.0650 | 01 Feb 2018 | 09 Mar 2018 | 23 Mar 2018 |
15 Dec 2017 | $0.0650 | 07 Dec 2017 | 18 Dec 2017 | 28 Dec 2017 |
07 Sep 2017 | $0.0650 | 24 Aug 2017 | 08 Sep 2017 | 21 Sep 2017 |
07 Jun 2017 | $0.0650 | 05 May 2017 | 09 Jun 2017 | 23 Jun 2017 |
08 Mar 2017 | $0.0650 | 03 Feb 2017 | 10 Mar 2017 | 24 Mar 2017 |
08 Dec 2016 | $0.0650 | 02 Dec 2016 | 12 Dec 2016 | 22 Dec 2016 |
07 Sep 2016 | $0.0650 | 26 Aug 2016 | 09 Sep 2016 | 20 Sep 2016 |
07 Jun 2016 | $0.0600 | 06 May 2016 | 09 Jun 2016 | 24 Jun 2016 |
09 Mar 2016 | $0.0600 | 05 Feb 2016 | 11 Mar 2016 | 25 Mar 2016 |
15 Dec 2015 | $0.0600 | 04 Dec 2015 | 17 Dec 2015 | 28 Dec 2015 |
17 Sep 2015 | $0.0600 | 11 Sep 2015 | 21 Sep 2015 | 02 Oct 2015 |
09 Jun 2015 | $0.0600 | 08 May 2015 | 11 Jun 2015 | 25 Jun 2015 |
10 Mar 2015 | $0.0600 | 06 Feb 2015 | 12 Mar 2015 | 26 Mar 2015 |
11 Dec 2014 | $0.0600 | 05 Dec 2014 | 15 Dec 2014 | 29 Dec 2014 |
11 Sep 2014 | $0.0600 | 05 Sep 2014 | 15 Sep 2014 | 29 Sep 2014 |
10 Jun 2014 | $0.0600 | 09 May 2014 | 12 Jun 2014 | 27 Jun 2014 |
11 Mar 2014 | $0.0600 | 07 Feb 2014 | 13 Mar 2014 | 28 Mar 2014 |
12 Dec 2013 | $0.0600 | 06 Dec 2013 | 16 Dec 2013 | 27 Dec 2013 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -10.84 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.477 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.648 | 1.500 | -8.31 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 14.34 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 14.18 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 14.18 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0684 | -1.500 | 8.86 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 3 561.64 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.169 | 2.00 | -0.390 | -0.780 | [0 - 30] |
freeCashFlowPerShareTTM | -1.205 | 2.00 | -0.602 | -1.205 | [0 - 20] |
debtEquityRatioTTM | 0.0774 | -1.500 | 9.69 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.382 | 1.000 | 6.97 | 6.97 | [0.2 - 0.8] |
operatingProfitMarginTTM | -11.60 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -4.62 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.0440 | 0.800 | -3.04 | -2.43 | [0.5 - 2] |
Total Score | 0.755 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.831 | 1.000 | -0.185 | 0 | [1 - 100] |
returnOnEquityTTM | -0.648 | 2.50 | -5.34 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.205 | 2.00 | -0.402 | -1.205 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.169 | 2.00 | -0.390 | -0.780 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0612 | 1.500 | -3.74 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -7.17 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.74 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Aceto Corporation
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं